Shares of TT Electronics (LON: TTG) are rallying on Thursday, trading over 13% higher at 238p.
TT released a statement not long after the share price increase, stating that they note today’s rise and provided an update on evaluation trials in the UK of Virolens, a rapid COVID-19 screening device for TT, the exclusive manufacturing partner.
The provider of engineered electronics said that the “Medicines and Healthcare products Regulatory Authority (MHRA), which is responsible for ensuring that medical devices meet applicable standards of safety, quality and efficacy, is in the final stages of registering Virolens for use and sale in Great Britain.”
WELCOME BONUS
Trade Thousands Of Global Markets
Demo account, mobile app and multi-platform access
IG
Visit Site
Empfohlener Broker
Multi Asset Platform
They added that any revenue they receive following the registration would be dependent on iAbra’s potential end customers in Great Britain converting interest into orders.
iAbra is a technology company that developed Virolens in partnership with TT.
There has been a high proportion of the commercial interest in Virolens, although, to date, it has been outside of Great Britain.
“There continues to be a wide range of potential commercial outcomes and hence no certainty as to the financial impact on TT,” said the company.
Should You Invest in TT Electronics Shares?
One of the most frequently asked questions we receive is, “what stocks are best to buy right now?” It’s a wide-ranging question, but one that we have answered… Our AskTraders stock analysts regularly review the market and compile a list of which companies you should be adding to your portfolio, including short and longer-term positions. Here are the best stocks to buy right now